Context Therapeutics (6K9.F) Q3 2024 Earnings

7AugConfirmed
Q2 2024
Q3 2024
-0.41
-0.29
-0.16
-0.04

Details

Expected EPS
-0.061031638490000005
Actual EPS
-0.0366188
Surprise EPS
0.02
Surprise Percent
+40%

Description

Context Therapeutics (6K9.F) has reported earnings of -0.0366188 per share for Q3 2024.

0 Comments

Share your thoughts